+ Watch PSDV
on My Watchlist
A drug delivery company focusing on the development of products utilizing its proprietary technologies for targeted and controlled drug delivery.
Sivida Limited is engaged in the development and commercialization of drug delivery products in the healthcare sector, initially in ophthalmology and oncology. The principal activities of the Company and its subsidiaries during the fiscal year ended June 30, 2006, included patent maintenance and lodgement of new patents with regard to its drug delivery platform technologies; collaboration and commercialization of applications to its platform technologies; promotion of the Company both domestically and internationally, and further investigation of future collaboration partners and product applications. In December 2005, pSivida Limited acquired Control Delivery Systems Inc (CDS). CDS designs and develops drug delivery products. On completion of the acquisition, CDS was renamed pSivida Inc.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions